Articles
May 3, 2023
Building a Corporate Responsibility Program from the Ground Up: Key Learnings from Alnylam ...
If you are building your program or assessing your program, here are five key learnings which may be helpful to your organization
Read More ›
April 24, 2023
2022 Annual Report: CEO Yvonne Greenstreet Reflects on the Next Chapter in the RNAi Revolu ...
Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2022 and highlights of the 2022 annual report.
Read More ›
March 29, 2023
Leading by Example in Gender Diversity Among Executive Leadership
Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.
Read More ›
March 10, 2023
Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics
Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics
Read More ›
March 2, 2023
Alnylam Named One of Fast Company's Most Innovative Companies for 2023
Alnylam is one of Fast Company's Most Innovative Companies for 2023, and is ranked #5 in the Medicines and Therapeutics category.
Read More ›
February 28, 2023
The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disease ...
Rare Disease Day unites the community to spread awareness and support the millions of people worldwide living with with a rare disease.
Read More ›
January 31, 2023
Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row
Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row.
Read More ›
December 8, 2022
Alnylam Named One of America's Most Responsible Companies by Newsweek
Alnylam has been named one of America's Most Responsible Companies for 2023 by Newsweek and research firm Statista
Read More ›
November 30, 2022
Alnylam Named #1 Largest Employer in MA for 2nd Year in a Row by The Boston Globe
Alnylam is a Boston Globe Top Place to Work for the 8th consecutive year and the #1 ranked company on the "Largest Employers" list for the second year in a row
Read More ›
October 26, 2022
Alnylam Named #2 <em>Science Magazine</em> Top Biopharma Employer
Alnylam has been named the #2 Science Magazine Top Biopharma Employer for 2022, which marks our 4th year on the list.
Read More ›
